Section 8 of the Indian Patent Act: Neither an Idle Menace nor A Mere FormalityVarshney, Swati
Amendment to UK Patent Act provides further exception to patent infringement The UK government has recently scheduled an amendment to the 1977 Patents Act, which would exempt activities involved in preparing or running clinical tria... A Sklan - 《Pharmaceutical Patent Analyst》 被引量: 0发表: 20...
Historical Context of U.S. Bayh-Dole Act: Implications for Indian Government Funded Research Patent PolicyBayh-Doletech transfergovernment funded researchpatentsIPIndiaU.SWhile the broad outline of the rationale for the U.S. Bayh-Dole Act is generally well known, the details of the Act's ...
Globally big Indian Biopharmaceutical companies are also keeping eyes to patent their biological inventions to increase their longevity and monopoly in the market. Unfortunately, there are no clear criteria's for patentable matters in biotechnological inventions under Indian patent act 2005.Gupta, ...
This article reports that Left wing parties in India have secured a series of amendments that water down the protection given to product patents in the country's Patent Act. The government introduced a bill into parliament on March 18, 2005 to replace a last-minute Ordinance it issued in ...
The Patent Act, 1970 was the first patent act to the independent India. It had provision for only process patent but did not have any provision for product patent. Therefore the process could have been patented but not the end product which gave rise to the concept of reverse mechanism. ...
One of the major and most influential amendment is the Patent (Amendment) Act, 2005. This act has provided new dimensions and horizons to the Indian pharmaceutical industry and a good number or rational researches have been performed on this subject. It has thus been a fascinatio...
Now that the first product patent in the pharmaceutical sector has been granted (Patent No. 198952 granted on 21st February, 2006 to Roche, on pegylated interferon-伪 conjugates) and a challenge to a key amendment has come to an unsuccessful end at the Madras High Court, this paper takes a...
Controvery of Section 3(D) of the Indian Patent ActWe shall be discussing the amendment which the Indian government made to their Intellectual property laws in 2005 and the effects it is having to the rest of thDaureeawo, RaheelSocial Science Electronic Publishing...
Trade-Related Issues of Intellectual Property Rights and the Indian Patent Act—A Negotiating Strategydoi:10.54648/woco1988013Ramesh B. SaxenaWorld Competition